Cargando…
Neurotrophins and their involvement in digestive cancers
Cancers of the digestive system, including esophageal, gastric, pancreatic, hepatic, and colorectal cancers, have a high incidence and mortality worldwide. Efficient therapies have improved patient care; however, many challenges remain including late diagnosis, disease recurrence, and resistance to...
Autores principales: | Blondy, Sabrina, Christou, Niki, David, Valentin, Verdier, Mireille, Jauberteau, Marie-Odile, Mathonnet, Muriel, Perraud, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370832/ https://www.ncbi.nlm.nih.gov/pubmed/30741921 http://dx.doi.org/10.1038/s41419-019-1385-8 |
Ejemplares similares
-
Neurotensin pathway in digestive cancers and clinical applications: an overview
por: Christou, Niki, et al.
Publicado: (2020) -
E-cadherin: A potential biomarker of colorectal cancer prognosis
por: Christou, Niki, et al.
Publicado: (2017) -
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
por: Blondy, Sabrina, et al.
Publicado: (2020) -
Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer
por: Mazouffre, Clément, et al.
Publicado: (2017) -
Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
por: Blondy, Sabrina, et al.
Publicado: (2020)